Executive Summary The FDA allows the import of generics and the domestic manufacturer and sale of generics that it knows are not bioequivalent to the original drug. Introduction It is amazing to read articles that touch on how the FDA works or what it produces at a high level and then find out how it…
Executive Summary We offer hospital and cancer center analysis. We were asked what the value added to this analysis over what a patient can find out independently. Introduction Hospital selection is tricky. This is particularly true as most patients undergoing the selection process have little experience with the hospital system. Wait One Second… Why is…
Executive Summary For decades the FDA has made false claims regarding its ability to inspect and provide quality assurance on Indian and Chinese drug manufacturing facilities. Introduction It has proven much easier to claim to inspect Indian and Chinese drug manufacturing facilities than to do it in reality effectively. Wait One Second… Why is The…
Executive Summary Africa receives inexpensive but also low-quality drugs from both India and China. Introduction The quality of drugs shipped to Africa by both China and India is, on average, very low. Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of the article because of two potential reasons….
Executive Summary Ranbaxy was an enormous Indian pharmaceutical company caught following manufacturing standards that are very common in India. Introduction It is difficult for Western audiences to wrap their heads around the manufacturing quality oversights commonplace in India. Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of the…
Executive Summary It’s always good to understand the actual side effects of all drugs. Recently we received a question regarding the potential liver toxicity of Ivermectin. Introduction The liver is the primary organ that removes drugs from the bloodstream. The most toxic drugs are the most harmful to the liver, and the worst drugs put…
Executive Summary The FDA claims high degrees of bioequivalence without having evidence that what they say is accurate. Introduction There is a common presentation that generics are identical to brand-name drugs. Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of the article because of two potential reasons. Reason…
Executive Summary Indian responses to Indian pharmaceutical companies falsifying bioequivalence are highly predictable. Introduction Indians and Indian regulatory bodies do not care much about drug safety, which is an observation from many sources. And this is also found in the reactions when Indian drug companies are caught engaging in bioequivalence and manufacturing fraud. Wait One…
Executive Summary Remicade is taken for autoimmune disorders. What was never done with Remicade’s FDA approval was to evaluate any cost-benefit for this drug. Introduction Remicade has significant side effects for improvement against autoimmune diseases. It also comes high costs and exaggerated benefits. This article will begin by discussing its financial costs and then move…
Executive Summary Humira has major side effects that need to be understood. Introduction The side effects of Humira are enormous and very serious. Wait One Second… Why is The Article Not Viewable? You are seeing this text instead of the article because of two potential reasons. Reason #1: You are a Subscriber but Not Signed…